Beard, G. Neurasthenia, or nervous exhaustion. Boston Med Surg J
1869; 3: 217–21.
Holmes, GP, Kaplan, JE, Gantz, NM, Komaroff, AL, Schonberger, LB, Straus, SE, Jones, SF, Dubois, RE, Cunningham-Rundles, C, Pahwa, S. Chronic fatigue syndrome: a working case definition. Ann Intern Med
1988; 108: 387–9.
Sharpe, MC, Archard, LC, Banatvala, JE, Borysiewicz, LK, Clare, AW, David, A, Edwards, RH, Hawton, KE, Lambert, HP, Lane, RJ, McDonald, EM, Mowbray, JF, Pearson, DJ, Peto, TEA, Preedy, VR, Smith, AP, Smith, DJ, Taylor, DJ, Tyrrell, DA, Wessely, S, White, PD. A report – chronic fatigue syndrome: guidelines for research. J R Soc Med
1991; 84: 118–21.
Fukuda, K, Straus, SE, Hickie, I, Sharpe, MC, Dobbins, JG, Komaroff, A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med
1994; 121: 953–9.
Whiting, P, Bagnall, AM, Sowden, AJ, Cornell, JE, Mulrow, CD, Ramirez, G. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review. JAMA
2001; 286: 1360–8.
Chambers, D, Bagnall, AM, Hempel, S, Forbes, C. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review. J R Soc Med
2006; 99: 506–20.
Stubhaug, B, Tveito, TH, Eriksen, HR, Ursin, H. Neurasthenia, subjective health complaints and sensitization. Psychoneuroendocrinology
2005; 30: 1003–9.
Hickie, I, Lloyd, A, Wakefield, D, Parker, G. The psychiatric status of patients with the chronic fatigue syndrome. Br J Psychiatry
1990; 156: 534–40.
Winokur, A, Sateia, MJ, Hayes, JB, Bayles-Dazet, W, MacDonald, MM, Gary, KA. Acute effects of mirtazapine on sleep continuity and sleep architecture in depressed patients: a pilot study. Biol Psychiatry
2000; 48: 75–8.
Aslan, S, Isik, E, Cosar, B. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep
2002; 25: 677–9.
Kasper, S. Efficacy of antidepressants in the treatment of severe depression: the place of mirtazapine. J Clin Psychopharmacol
1997; 17 (suppl 1): S19–28.
Holm, KJ, Markham, A. Mirtazapine: a review of its use in major depression. Drugs
1999; 57: 607–31.
Freynhagen, R, Muth-Selbach, U, Lipfert, P, Stevens, MF, Zacharowski, K, Tölle, TR, von Giesen, JH. The effect of mirtazapine in patients with chronic pain and concomitant depression. Curr Med Res Opin
2006; 22: 257–64.
Samborski, W, Lezanska-Szpera, M, Rybakowski, JK. Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry
2004; 37: 168–70.
World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. WHO, 1993.
World Health Organization. Schedules for Clinical Assessment in Neuropsychiatry (SCAN). WHO, 1992.
Chalder, T, Berelowitz, G, Pawlikowska, T, Watts, L, Wessely, S, Wright, D, Wallace, EP. Development of a fatigue scale. J Psychosom Res
1993; 37: 147–53.
Eriksen, HR, Ihlebaek, C, Ursin, H. A scoring system for subjective health complaints (SHC). Scand J Public Health
1999; 27: 63–72.
Ware, JE, Snow, KK, Kosinski, M. SF-36 Health Survey Manual and Interpretation Guide. Quality Metric Inc, 2000.
Loge, JH, Kaasa, S, Hjermstad, MJ, Kvien, TK. Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol
1998; 51: 1069–76.
Ware, JE, Kosinski, M. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of ver 1. Quality Metric Inc, 2001.
Guy, W. CGI Clinical Global Impressions. In ECDEU Assessment Manual for Psychopharmacology
217–22. National Institute for Mental Health, 1976.
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
Hamilton, M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol
1967; 6: 278–96.
Moss-Morris, R, Weinman, J, Petrie, KJ, Horne, R, Cameron, LD, Buick, D. The Revised Illness Perception Questionnaire (IPQ-R). Psychol Health
2002; 17: 1–16.
Astrand, PO, Ryhming, I. A nomogram for calculation of aerobic capacity (physical fitness) from pulse rate during sub-maximal work. J Appl Physiol
1954; 7: 218–21.
Brown, EG, Wood, L, Wood, S. The medical dictionary for regulatory activities (MedDRA). Drug Saf
1999; 20: 109–17.
Skatteboe, UB, Friis, S, Hope, MK, Vaglum, P. Body awareness group therapy for patients with personality disorders. 1. Description of the therapeutic method. Psychother Psychosom
1989; 51: 11–17.
van Mens-Verhulst, J, van Dijkum, C, van Kuijk, E, Lam, N. The self-regulation of fatigue and associated complaints: an exploratory simulation. Patient Educ Couns
2003; 49: 53–7.